|Bid||31.30 x 800|
|Ask||31.39 x 1300|
|Day's range||29.76 - 31.43|
|52-week range||24.75 - 57.00|
|Beta (5Y monthly)||0.58|
|PE ratio (TTM)||23.25|
|Earnings date||25 Oct 2021 - 29 Oct 2021|
|Forward dividend & yield||1.20 (3.82%)|
|Ex-dividend date||05 Aug 2021|
|1y target est||31.50|
Welcome to the 1-800-PetMeds Conference Call to review the Financial Results of the First -- excuse me, of the First Fiscal Quarter Ended on June 30th, 2021. Founded in 1996, 1-800-PetMeds is America's most trusted pet pharmacy delivering prescription and non-prescription pet medications and other health products for dogs, cats and horses direct to consumer. 1-800-PetMeds markets its products through national advertising campaigns which direct consumers to order by phone or on the Internet and which aim to increase the recognition of the PetMeds family of brand names.
The stock market has seen a lot of violent moves among individual stocks lately, and that's played a role in the volatility in the Nasdaq Composite (NASDAQINDEX: ^IXIC). As of 12:30 p.m. EDT, most major market benchmarks were little changed, but the Nasdaq was down almost a full percentage point. Investors are paying a lot of attention to so-called "meme stocks," especially those in which large institutional investment companies have taken significant short positions.
Shares of PetMed Express (NASDAQ: PETS) were sinking 22.8% as of 10:54 a.m. EDT on Thursday. Lebiedzinksi's downgrade of PetMed came following a big spike for the online pet pharmacy stock on Wednesday. This sizzling gain appeared to be related to traders in some online communities viewing PetMed Express as a good short squeeze candidate.